课题基金 / 基金详情

Institutional Career Development Core

Institutional Career Development Core
机构职业发展核心
批准号:
10394233
负责人:
JASON G UMANS
金额:
$36.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-28 至 2025-03-31

项目摘要

项目成果

JASON G UMANS的其他基金

相似基金

相关文献

中文摘要
翻译
该计划建立在我们之前运营一个非常成功的“小型枢纽”的经验教训之上 KL 2计划,扩展了我们成熟的导师/学员培训战略,以提高协作技能 和团队科学,并为从事潜在的初级教师学者到临床和转化研究之前, 他们通常能够竞争一个K资助的职位。我们建议与附近的新合作 CTSA中心,并继续设计和评估新的培训经验,然后与国家 CTSA财团。我们的计划利用了与我们的所有其他核心合作的网络, 乔治城-霍华德大学临床和转化科学中心(GHUCCTS)中心, 整合和协同与我们的TL 1前和博士后计划。我们利用一个非常有资格的 来自乔治敦大学和霍华德大学以及MedStar Health的申请人群体, 先前的科学和专业培训,学科,翻译阶段,研究重点,性别,种族和 种族这种多样性为我们高度个性化和以能力为基础的培训计划提供了信息, 平等多样的双/团队导师制,以促进跨学科协作团队科学的追求 解决重大的健康差距问题。我们的KL 2职业发展计划旨在1)指导 研究职业发展的特别有前途的初级教师翻译研究人员从任何 GHUCCTS内的学科、部门或合格机构; 2)个性化开发和培训 为每个KL 2学者制定计划,同时确保在负责任的行为中有共同的价值观和行为核心 研究,团队科学技能和转化研究的核心能力; 3)丰富管道 和社区的初级教师翻译学者,特别是从群体的历史上代表不足, 生物医学研究,通过设计和扩大讲习班、课程、指导经验和新的培训 为我们的学者和那些还没有准备好竞争KL 2支持或其他职业途径的人提供方法, 他们都可能有助于严谨和有影响力的翻译研究。我们提出一个评估计划, 侧重于计划过程和成果的学者(期间和培训后),导师,课程, 教育经验,项目领导和管理沿着具体的指标和建议 委员会的意见,以有利于关键的修订和持续改进的建议的职业生涯 发展计划。
英文摘要
The program builds on lessons learned from our prior experience in operating a highly successful “small hub” KL2 program, expands our proven strategies for mentor/mentee training, for enhancing skills in collaboration and team science, and for engaging potential junior faculty scholars into clinical and translational research before they would normally be able to compete for a K-funded position. We propose new collaborations with nearby CTSA Hubs and to continue to design and evaluate novel training experiences to then be shared with the national CTSA consortium. Our program leverages a meshwork of collaborations with all of the other cores in our Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) Hub and is tightly integrated and synergistic with our TL1 pre- and postdoctoral programs. We draw upon a richly-qualified applicant pool from Georgetown and Howard Universities and from MedStar Health that is diverse with respect to prior scientific and professional training, discipline, translational stage(s), research focus, gender, race and ethnicity. This diversity informs our highly individualized and competency-based training program, anchored by equally-diverse dual/team mentorship in order to favor the pursuit of collaborative interdisciplinary team science addressing important health disparities. Our KL2 career development program aims to 1) guide the mentored research career development of exceptionally-promising junior faculty translational investigators from any discipline, department, or eligible institution within GHUCCTS; 2) individualize the development and training plans for each KL2 Scholar, while ensuring a common core of values and behaviors in the responsible conduct of research, skills in team science, and core competencies in translational research; and 3) enrich the pipeline and community of junior faculty translational scholars, especially from groups historically underrepresented in biomedical research, by design and expansion of workshops, courses, mentored experiences and novel training methods for our scholars and for those not yet ready to compete for KL2 support or in other career pathways, so that they all may contribute to rigorous and impactful translational research. We propose an evaluation plan that focused on both program process and outcomes for scholars (during and after training), mentors, curricula, educational experiences, program leadership and administration along with specific metrics and advisory committee input in order to favor critical revision and continued improvement of the proposed career development program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRONG HEART STUDY (SHS) - FIELD CENTER, TASK ORDER 001, BASE PERIOD, FEBRUARY 15, 2019 TO FEBRUARY 14, 2020
STRONG HEART STUDY (SHS) - FIELD CENTER, TASK ORDER 001, BASE PERIOD, FEBRUARY 15, 2019 TO FEBRUARY 14, 2020
STRONG HEART STUDY (SHS) - FIELD CENTER, TASK ORDER 001, BASE PERIOD, FEBRUARY 15, 2019 TO FEBRUARY 14, 2020
STRONG HEART STUDY (SHS) - FIELD CENTER, TASK ORDER 001, BASE PERIOD, FEBRUARY 15, 2019 TO FEBRUARY 14, 2020
海外基金